EPISODE · Jun 6, 2024 · 1 MIN
Botox Breakthrough for Depression
from AI Automation Minute · host Dr. Teri Fisher
Dive into today's episode of Aesthetic Medicine Minute, where we explore groundbreaking research on using botulinum toxin A (BTA) to treat major depressive disorder (MDD). Discover how BTA injections in the glabellar region could revolutionize depression treatment, significantly improving symptoms and potentially offering a new therapeutic option. Learn about the promising results from recent trials and the facial feedback hypothesis, which may explain the mood-lifting effects of BTA. Join us for an insightful look into this innovative approach and what it could mean for the future of mental health treatments. Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for healthcare: 🎥 Watch on YouTube for in-depth AI tutorials: YouTube.com/@DrTeriFisher📲 Follow on Instagram for automation tips: @DrTeriFisher💡 Discover AI tools for your practice: DrTeriFisher.com🎙 Listen to the long-form podcast: Anti-Aging Insights 👉 Subscribe to AI Automation Minute for your daily dose of AI-powered efficiency, and share with colleagues who want to work smarter, not harder! #AIAutomationMinute #DrTeriFisher #HealthcareAI
Embed this episode
What this episode covers
Dive into today's episode of Aesthetic Medicine Minute, where we explore groundbreaking research on using botulinum toxin A (BTA) to treat major depressive disorder (MDD). Discover how BTA injections in the glabellar region could revolutionize depression treatment, significantly improving symptoms and potentially offering a new therapeutic option. Learn about the promising results from recent trials and the facial feedback hypothesis, which may explain the mood-lifting effects of BTA. Join us...
Ready to play
Botox Breakthrough for Depression
No transcript for this episode yet
Similar Episodes
No similar episodes found.